FindTrial
Sign In

Effects of Atosiban on clinical outcomes of in vitro fertilization-embryo transfer

Effects of Atosiban on clinical outcomes of in vitro fertilization-embryo transfer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020795
Enrollment
Unknown
Registered
2019-01-19
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in-vitro fertilization

Interventions

2:inject atosiban
Group 1:N.S. 0.9ml

Sponsors

Northwest Women's and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 43 Years

Inclusion criteria

Inclusion criteria: 1. IVF/ICSI treatment in our ART center; 2. have more than 1 top quality embryo; 3. infertility factors are tubal, EMs, ovulation disorder; 4. endometrium thicker than 7mm; 5. basal FSH<12U/L

Exclusion criteria

Exclusion criteria: 1. patients with severe endocrine disease and other systematic disease; 2. severe uterus abnormally and hydrosalpinx.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;—

Countries

China

Contacts

Public ContactXitong Liu

Northwest Women's and Children's Hospital

liuxitong1989@qq.com+86 13484620246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026